Prizes and awards
The IAS, together with its partners, sponsors a number of scientific prizes and awards to reward promising researchers who are conducting outstanding work in HIV research.
IAS/ANRS Lange/Van Tongeren Prizes for Young Investigators – Annual Prizes
The US$2,000 Lange/Van Tongeren Young Investigator Prizes are jointly funded by the IAS and the France Recherche Nord & Sud Sida-HIV Hépatites (ANRS) to support young researchers who demonstrate innovation, originality, rationale and quality in the field of HIV research. One prize is presented to the top-scoring abstract in each of the four conference tracks. In 2015, the Young Investigator Prize was permanently renamed in memory of Joep Lange and Jacqueline van Tongeren.
IAS/ANRS Dominique Dormont Prize – Annual prize
The US$5,000 IAS-ANRS Dominique Dormont Prize is funded by the Dominique Dormont Association to support young researchers working on chronic conditions in humans, with a particular focus on the interface between HIV and other chronic diseases. The prize highlights researchers who demonstrate originality, rationale, quality and a multidisciplinary and integrative approach in the field of HIV and AIDS research.
IAS TB/HIV Research Prizes – Annual prizes
The five US$2,000 IAS TB/HIV Research Prizes are incentives for young and established researchers to investigate pertinent research questions that affect TB/HIV co-infection and operational effectiveness of implementing core TB/HIV collaborative services. The prizes are presented to the two top-scoring abstracts in any of these areas.
IAS Injecting Drug Use Research Prizes – Annual prizes
The five US$2,000 IAS Injecting Drug Use Research Prizes are incentives for researchers to address important research questions around the management of HCV infection and/or HIV/HCV co-infection in people who inject drugs, particularly through interdisciplinary research on drug dependence, harm reduction and/or drug policy. The prizes are presented to the three top-scoring abstracts in any of these areas.
CIPHER Research Grant – Annual programme
The CIPHER Research Grant provides a unique opportunity for early-stage investigators to address targeted research gaps in paediatric and adolescent HIV in resource-limited settings for evidence-informed policy. The grants are for up to US$150,000 for up to two years, and 80% of grants awarded go to applicants from low- and middle-income countries. CIPHER is an initiative of the IAS; it is made possible through support from CIPHER Founding Sponsor ViiV Healthcare and Janssen.
CIPHER Growing the Leaders of Tomorrow Fellowship Programme – Biannual programme
The CIPHER Growing the Leaders of Tomorrow Fellowship Programme contributes to strengthened HIV clinical research capacity in high-burden countries in sub-Saharan Africa by providing two-year research fellowships to emerging young leaders in paediatric HIV clinical science. The fellowship provides up to US$70,000 for the fellow to work with an established mentor on a funded research project that addresses a key gap in paediatric HIV clinical science. CIPHER is an initiative of the IAS; this programme is made possible through support from CIPHER Founding Sponsor ViiV Healthcare.
IAS/Abivax Research-for-Cure Academy Fellowship Prize – Annual prize
The IAS Research-for-Cure Academy provides training on state-of-the-art HIV cure research to talented early- to mid-career investigators and clinical scientists working in resource-constrained settings. This US$2,000 annual prize is presented to one outstanding fellow based on their engagement during the academy, collaborative spirit during the project work and continued engagement in the HIV cure field.
IAS/MSD Prize for Operational and Implementation Research in Differentiated Service Delivery
The International AIDS Society (IAS) and Merck Sharpe & Dohme (MSD) award a co-partnered prize for the top-scoring abstracts in operational and implementation research in differentiated service delivery. The prize recognizes outstanding research that addresses key knowledge gaps and links new evidence to strategic programme priorities in differentiated service delivery. The prize (US$10,000 per recipient) is awarded to the four highest-scoring abstracts. It is funded by MSD.